Vienna, Austria, December 17, 2018 / PRNewswire/ – Today Lexogen launches a Version 2 (V2) upgrade for the TeloPrime Full-Length cDNA Amplification Kit; an all-in-one protocol for generating 5’ cap-specific full-length cDNA from as little as 1 ng of total RNA. The new TeloPrime V2 Kits provide higher yields and enhanced representation of longer cDNAs than the... Read more
2018-12-17 New site offers system demonstrations for customers as well as metrology services OBERKOCHEN/Germany; Lyon, Michigan/USA, 2018-12-17. With the official groundbreaking, ZEISS has started the construction of a new modern site outside of Detroit. The new facility for the Industrial Quality and Research (IQR) segment of ZEISS, represented in the USA by Carl Zeiss Industrial... Read more
ETTLINGEN, Germany, December 14th, 2018 – Today, Bruker announced the launch of the INVENIO S Fourier Transform Infrared (FTIR) research spectrometer. The novel INVENIO S is a research FTIR spectrometer for advanced routine analysis and spectroscopic reseach and replaces the previous TENSOR spectrometer series. The INVENIO S is a peak performance FTIR spectrometer focused on maximum... Read more
PDF Version SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its previously announced underwritten public offering of 9,372,500 shares of its common stock. The stock was sold at a price to the public of $6.75 per share, for aggregate gross proceeds of... Read more
Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III (704) 871-3290 STATESVILLE, N.C. December 13, 2018 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) announced today the resignation of William A. Shumaker as Chairman of the Board of Directors and as a Director of the Company, effective January 31, 2019. Mr. Shumaker cited personal reasons as... Read more
2018/12/13http://www.ymc.co.jp/uploads/595/stainless_precolumn_filters_E.pdf Read more
December 18, 2018 ~ Services and Capacity Increase with New Site Opening ~ (San Diego, Calif., December 13, 2018) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently announced the expansion of its existing translational oncology research capacity by opening... Read more
LANSING, Mich., Dec. 12, 2018 — Neogen’s one-hour Listeria Right Now™ environmental pathogen detection system has been certified by the AOAC for use with samples on three additional surfaces. Listeria Right Now achieved its original AOAC approval (license number #081802) in August for use with samples obtained from stainless steel and sealed concrete surfaces. The test kit has now... Read more
BD FACSLyric™ Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program Certification FRANKLIN LAKES, N.J., Dec. 11, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL. This independent assessment evaluates corporate cybersecurity programs and policies to... Read more
PDF Version SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an underwritten public offering of 8,150,000 shares of its common stock at a price to the public of $6.75 per share for aggregate gross proceeds of approximately $55 million. Fluidigm has granted to the underwriters... Read more